XML 66 R46.htm IDEA: XBRL DOCUMENT v3.19.3
Collaboration Agreements - Aurigene Discovery Technologies Limited (Aurigene) Collaboration (Details)
$ in Millions
1 Months Ended
Jul. 31, 2019
USD ($)
program
Sep. 27, 2019
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Additional option payments $ 7.5  
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration agreement, number of programs | program 6  
Upfront payment $ 10.0  
Collaboration agreement, number of preexisting programs | program 3  
Collaboration agreement, number of drug discovery programs | program 3  
Research and development obligation $ 32.6  
Preclinical development funding commitment accrued   $ 1.3
Maximum amount eligible for development and regulatory milestones 148.8  
Maximum amount eligible for commercial milestones under collaborations agreement 280.0  
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Minimum    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Option exercise fee payment, if exercised 10.0  
Collaboration Agreement With Aurigene Discovery Technologies Limited Collaboration Agreement | Maximum    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Option exercise fee payment, if exercised $ 12.0